(task) WHO to Review Merck’s Investigational Ebola Vaccine for Emergency Use Assessment and Listing | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology

GRS, All Africa RSs

4

vaccine, Ebola

> Begin forwarded message:
>
> From: Albert Gomez <albert@icassemblies.com>
> Subject: WHO to Review Merck’s Investigational Ebola Vaccine for Emergency Use Assessment and Listing | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology
> Date: December 29, 2015 at 7:14:26 PM EST
> To: Michael Mcdonald <michael.d.mcdonald@mac.com>, Kathy MPHISE <gilbojer@aol.com>
>
>
> http://www.americanpharmaceuticalreview.com/1315-News/181581-WHO-to-Review-Merck-s-Investigational-Ebola-Vaccine-for-Emergency-Use-Assessment-and-Listing/
>
>
> Best Regards,
>
> Albert Gomez
> Industrial Components
>
> 305-477-0387x15
> 305-321-3214